A judge in New Jersey has given the go-ahead for what could be multi-billion dollar litigation surrounding insulin companies and the alleged over-inflated prices charged to consumers.

In court documents released Wednesday, U.S. District Court Judge Brian R. Martinotti established a leadership structure to control and manage the litigation across the entire multi-district litigation (MDL) involving alleged Insulin pricing schemes in the U.S.